About this approach
Monoclonal antibodies are laboratory-made proteins that bind particular targets. Depending on the medicine, they may block a growth signal, mark cancer cells for immune attack, bring immune cells together with cancer cells, or carry a drug or radioactive payload. The target and drug name matter more than the broad category alone.
Where it fits: Targeted or immune treatment used across many cancers
Where this treatment is used
Many monoclonal antibodies are approved across blood cancers and solid tumors. Some are classified as targeted therapy and others as immunotherapy.
Procedure and practical considerations
Infusion or injection reactions, infection, skin changes, high blood pressure, heart or lung effects, and immune complications may occur, depending on the antibody. Monitoring should follow the specific medicine rather than a generic antibody checklist.
Clinics reporting this approach
These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.
Sources
Source information checked: 2026-10-07. The links below identify the public and clinic-provided materials used for this page.
Compiled by: Cancer Clinic Finder Editorial Team
- NCI: Monoclonal Antibodies ↗Checked 2026-10-07
- National Cancer Institute: Types of Cancer Treatment ↗Checked 2026-10-07
How Cancer Clinic Finder compiles information · Suggest a factual correction
